SOCS-1 tvas originally identified as an inhibitor of interleukin-6 signal t
ransduction and is a member of a family of proteins (SOCS-1 to SOCS-7 and C
IS) that contain an SH2 domain and a conserved carboxyl-terminal SOCS box m
otif. Mutation studies have established that critical contributions from bo
th the amino-terminal and SH2 domains are essential for SOCS-1 and SOCS-3 t
o inhibit cytokine signaling. inhibition of cytokine-dependent activation o
f STAT3 occurred in cells expressing either SOCS-1 or SOCS-3, but unlike SO
CS-1, SOCS-3 did not directly interact with or inhibit the activity of JAK
kinases, Although the conserved SOCS box motif appeared to be dispensable f
or SOCS-1 and SOCS-3 action when overexpressed, this domain interacts with
elongin proteins and may be important in regulating protein turnover. In ge
ne knockout studies, SOCS-1(-/-) mice were born but failed to thrive and di
ed within 3 weeks of age with fatty degeneration of the liver and hemopoiet
ic infiltration of several organs. The thymus in SOCS-1(-/-) mice was small
, the animals were lymphopenic, and deficiencies in B lymphocytes were evid
ent within hemopoietic organs, We propose that the absence of SOCS-1 in the
se mice prevents lymphocytes and liver cells from appropriately controlling
signals from cytokines with cytotoxic side effects.